| Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ... Nature 583 (7815), 290-295, 2020 | 1795 | 2020 |
| A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins D Corti, J Voss, SJ Gamblin, G Codoni, A Macagno, D Jarrossay, ... Science 333 (6044), 850-856, 2011 | 1350 | 2011 |
| Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21, 2020 | 1326 | 2020 |
| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1225 | 2021 |
| Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1140 | 2022 |
| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 908 | 2021 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 868 | 2022 |
| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16, 2021 | 867 | 2021 |
| Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection K Stettler, M Beltramello, DA Espinosa, V Graham, A Cassotta, S Bianchi, ... Science 353 (6301), 823-826, 2016 | 849 | 2016 |
| An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ... Nature medicine 28 (3), 490-495, 2022 | 717 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 702 | 2021 |
| Unexpected receptor functional mimicry elucidates activation of coronavirus fusion AC Walls, X Xiong, YJ Park, MA Tortorici, J Snijder, J Quispe, E Cameroni, ... Cell 176 (5), 1026-1039. e15, 2019 | 622 | 2019 |
| Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 EB Hodcroft, M Zuber, S Nadeau, TG Vaughan, KHD Crawford, ... Nature 595 (7869), 707-712, 2021 | 588 | 2021 |
| Broadly neutralizing antiviral antibodies D Corti, A Lanzavecchia Annual review of immunology 31 (1), 705-742, 2013 | 586 | 2013 |
| A perspective on potential antibody-dependent enhancement of SARS-CoV-2 AM Arvin, K Fink, MA Schmid, A Cathcart, R Spreafico, ... Nature 584 (7821), 353-363, 2020 | 576 | 2020 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 565 | 2021 |
| Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine D Corti, AL Suguitan, D Pinna, C Silacci, BM Fernandez-Rodriguez, ... The Journal of clinical investigation 120 (5), 1663-1673, 2010 | 525 | 2010 |
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms MA Tortorici, M Beltramello, FA Lempp, D Pinto, HV Dang, LE Rosen, ... Science 370 (6519), 950-957, 2020 | 520 | 2020 |
| Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals D Corti, JPM Langedijk, A Hinz, MS Seaman, F Vanzetta, ... PloS one 5 (1), e8805, 2010 | 519 | 2010 |
| SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern M McCallum, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio, ... Science 373 (6555), 648-654, 2021 | 511 | 2021 |
Antonio LanzavecchiaNational Institute of Molecular Genetics, INGM, Milano, IT在 ingm.org 的电子邮件经过验证
